Krishna Institute of Medical Sciences Limited — Updates, 06-02-2025: Press Release

Consolidated Revenue for KIMS Hospitals reached INR 790 Cr, signifying a 29.7% year-over-year growth, with a 1.0% sequential increase. Consolidated EBITDA was INR 205 Cr, reflecting a robust 36.4% rise from the same period last year but down 8.1% from the prior quarter. The EBITDA margin improved to 25.9%, up from 24.7% in Q3 FY24, although it decreased from 28.5% in Q2 FY25. Profit After Tax (PAT) stood at INR 93 Cr, compared to INR 121 Cr in Q2 FY25 and INR 77 Cr in Q3 FY24.

Operationally, Average Revenue Per Occupied Bed (ARPOB) grew by 25.2% year-over-year, showing effective revenue management. On the clinical front, the hospitals achieved notable medical milestones, including complex surgeries and innovative treatments that highlight their expertise and advanced capabilities. This performance, coupled with strong operational metrics, presents a positive outlook for ongoing growth as new hospital units come online. Investors should monitor the company's potential growth as it leverages these capabilities for expansion.